The U.S. Food and Drug Administration today approved a 2nd cell-based gene therapy, to treat adult patients with certain types of large B-cell lymphoma who have not responded to or who have relapsed after at least two other kinds of treatment. “Today marks another milestone in the development of a whole new scientific paradigm for the treatment of serious diseases” said FDA Commissioner Scott Gottlieb, M.D.
Your Cure The Future donations have supported a ground-breaking discovery which may help find new treatments for cancer and other diseases. Dr Ulf Schmitz and Centenary Institute’s Gene & Stem Cell Therapy Program, led by Professor John Rasko AO, have – for the first time – discovered a common pattern in the process of gene regulation in humans, mice, dogs, chickens and zebrafish. A better understanding of this common process will help develop novel therapies and possible cures for diseases.